Augmenting Cost-Effectiveness Analysis Will Not Improve Affordability.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 32223607.
- Also identified by DOI 10.18553/jmcp.2020.26.4.407 and PMC identifier 10390905.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
No outside funding contributed to this article. The authors are employed by Premera Blue Cross and have nothing to disclose.
Medical subject headings
- Models, Economic